West Pharmaceutical Services, Inc.
WSTLast close · Oct 16, 2026384.02+1.00 (+0.26%)
Market cap$27.0B
Key indicators
Revenue3.3B+12.4% on a year earlier
1.7B
1.8B
2.1B
2.8B
2.9B
2.9B
2.9B
3.1B
3.3B
3.4B
3.6B
3.9B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 1.7B | 1.8B+7.1% | 2.1B+16.7% | 2.8B+31.9% | 2.9B+2.0% | 2.9B+2.2% | 2.9B−1.9% | 3.1B+6.3% | 3.3B+12.4% | 3.4B | 3.6B | 3.9B | |
| — | 7.1% | 16.7% | 31.9% | 2.0% | 2.2% | -1.9% | 6.3% | 12.4% | 9.8% | 6.2% | 7.4% | |
| $2.74 | $3.21+17.2% | $4.57+42.4% | $8.67+89.7% | $7.73−10.8% | $7.88+1.9% | $6.69−15.1% | $6.79+1.5% | $7.81+17.1% | $8.98 | $10.03 | $11.46 | |
| Profitability | ||||||||||||
| 31.8% | 32.9%+1.2 pt | 35.8%+2.8 pt | 41.5%+5.8 pt | 39.4%−2.2 pt | 38.3%−1.1 pt | 34.5%−3.8 pt | 35.9%+1.4 pt | 36.8%+1.5 pt | · | · | · | |
| 14.0% | 16.1%+2.1 pt | 19.0%+2.8 pt | 26.6%+7.6 pt | 25.4%−1.1 pt | 22.9%−2.5 pt | 19.7%−3.2 pt | 19.0%−0.7 pt | 20.5%+0.8 pt | · | · | · | |
| 12.0% | 13.1%+1.1 pt | 16.1%+3.0 pt | 23.4%+7.2 pt | 20.3%−3.1 pt | 20.1%−0.2 pt | 17.0%−3.1 pt | 16.1%−1.0 pt | 17.0%+0.5 pt | · | · | · | |
| 14.8% | 15.4%+0.5 pt | 18.7%+3.3 pt | 28.3%+9.7 pt | 21.8%−6.5 pt | 20.6%−1.2 pt | 18.4%−2.2 pt | 15.5%−2.8 pt | — | · | · | · | |
| Cash | ||||||||||||
| 183.9M | 240.8M+30.9% | 298.1M+23.8% | 330.6M+10.9% | 439.4M+32.9% | 414.5M−5.7% | 276.4M−33.3% | 468.9M+69.6% | 436.9M+27.0% | · | · | · | |
| 10.7% | 13.1%+2.4 pt | 13.9%+0.8 pt | 11.7%−2.2 pt | 15.2%+3.5 pt | 14.1%−1.2 pt | 9.6%−4.5 pt | 15.3%+5.7 pt | 13.1%+1.5 pt | · | · | · | |
| 42.1M | 45.1M+7.1% | 48.1M+6.7% | 51.1M+6.2% | 54.1M+5.9% | 57.0M+5.4% | 59.1M+3.7% | 61.2M+3.6% | — | · | · | · | |
| Balance sheet | ||||||||||||
| 0.14x | 0.16x+0.02x | 0.14x−0.03x | 0.11x−0.03x | 0.08x−0.03x | 0.07x−0.01x | 0.08x+0.00x | 0.06x−0.01x | 0.07x−0.00x | · | · | · | |
| 75.40M | 75.40M+0.0% | 75.80M+0.5% | 76.30M+0.7% | 75.80M−0.7% | 75.30M−0.7% | 73.70M−2.1% | 72.70M−1.4% | 71.30M−1.7% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.